Navigation Links
Omega Protein Reports 2007 Results
Date:3/12/2008

HOUSTON, March 12 /PRNewswire-FirstCall/ -- Omega Protein Corporation (NYSE: OME), the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $12.1 million ($0.72 a share) for the fiscal year ended December 31, 2007, compared with net income of $4.6 million ($0.19 a share) for the year ended December 31, 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO)

For the year ended December 31, 2007, the Company had revenues of $157.1 million, compared with $139.8 million in revenues for the year ended December 31, 2006. Omega Protein recorded operating income of $27.4 million for the year ended December 31, 2007, versus operating income of $8.0 million for the comparable period a year earlier.

Revenues for the fourth quarter ended December 31, 2007 were $44.3 million compared with revenues of $26.1 million for the comparable quarter in 2006. Omega Protein recorded operating income of $8.8 million for the 2007 fourth quarter, versus operating income of $0.1 million for the fourth quarter of 2006.

Omega Protein's 2007 results reflect increased margins primarily due to higher sales prices received during the current year, partially offset by a decline in sales volume of both fish meal and fish oil. Additionally, results for the three and twelve months ended December 31, 2007 were favorably impacted by the settlement of the lawsuit with its property insurance carriers pertaining to damages sustained from Hurricanes Katrina and Rita in 2005. The results for the year ended December 31, 2007 were also impacted by the net loss incurred during the first quarter of 2007 primarily due to the write-off of approximately $3.0 million in deferred debt issuance costs and prepayment fees resulting from the refinancing of the Company's prior credit agreement with a new credit facility which closed in March 2007. Excluding the settlement of the lawsuit and the write-off from the reported 2007 net income would have resulted in Omega Protein reporting approximately $7.2 million in net income ($0.43 a share).

About Omega Protein

Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward-looking statements include, among others: (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, fish oil yields, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; (3) Omega Protein's expectations regarding demand for OmegaPure(R) proving to be incorrect; and (4) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its reports on Form 10-K, Form 10-Q and Form 8-K. The Company also posts its latest internally generated price list for various products on its Company website, http://www.omegaproteininc.com. Pricing and product availability information disclosed in the price list are subject to change or discontinuance without prior notice, and the Company undertakes no obligation to update such information.

OMEGA PROTEIN CORPORATION

Statement of Operations

(unaudited)

Three Months Twelve Months

Ended December 31, Ended December 31,

2007 2006 2007 2006

(in thousands, except per share amounts)

Revenues $44,336 $26,104 $157,149 $139,834

Cost of sales 35,650 22,577 122,455 116,638

Gross profit 8,686 3,527 34,694 23,196

Selling, general

and administrative

expense 4,730 3,239 16,386 13,683

Research and

development expense 529 -- 1,194 --

(Insurance recoveries)

losses relating to

natural disaster

and other, net (5,393) 177 (10,326) 1,557

Operating income 8,820 111 27,440 7,956

Interest income

(expense), net (1,111) (895) (5,121) (1,938)

Loss resulting from

debt refinancing -- -- (3,024) --

Other income

(expense), net (87) (85) (333) (244)

Income (loss) before

income taxes 7,622 (869) 18,962 5,774

Provision (benefit)

for income taxes 2,839 (473) 6,823 1,202

Net income (loss) $4,783 $(396) $12,139 $4,572

Basic earnings

(loss) per share $0.27 $(0.02) $0.72 $0.19

Weighted average

common shares

outstanding 17,407 22,026 16,830 24,322

Diluted earnings

(loss) per share $0.27 $(0.02) $0.70 $0.18

Weighted average

common shares and

potential common

share equivalents

outstanding 17,768 22,026 17,432 25,200

OMEGA PROTEIN CORPORATION

CONDENSED BALANCE SHEET

(Unaudited)

December 31, December 31,

2007 2006

(in thousands)

ASSETS

Current assets $107,651 $89,759

Property and equipment, net 96,659 100,776

Deferred tax assets, net 175 4,103

Other assets 3,344 6,080

Total assets $207,829 $200,718

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities $24,190 $18,683

Long-term debt, less current

maturities 58,976 72,693

Pension liabilities, net and other 6,208 8,252

Stockholders' equity 118,455 101,090

Total liabilities and

stockholders' equity $207,829 $200,718

Book value per share outstanding $6.79 $6.24


'/>"/>
SOURCE Omega Protein Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Omega-3s Guard Against Type 1 Diabetes
2. Brain, Eye and Heart Health: Three Reasons to Eat More Omega-3s
3. Maine Natural Health Company Brings Omega-3 Benefits to Pets
4. Nordic Naturals Introduces Ultimate Omega 500 - Their Best Selling Formula Now Available in a Smaller Size Soft Gel!
5. Omega-3s Linked to Prevention of Parkinsons Disease and More
6. Nordic Naturals Professional Exclusive Division Redefines High Potency Omega-3 Supplementation With New Elite Line!
7. Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury
8. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
9. Draining away brains toxic protein to stop Alzheimers
10. Penn study finds pro-death proteins required to regulate healthy immune function
11. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: